Last reviewed · How we verify
NCT03887949
Comparison of Three Modes of Ventilation During Robot-assisted Hysterectomy in Trendelenburg Position
NA trial testing Group VCV in Anesthesia in 60 participants. Status unknown.
30 April 2019
Quick facts
| Lead sponsor | Hallym University Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 May 2018 |
| Primary completion | 30 April 2019 |
| Estimated completion | 31 May 2019 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Group VCV
- Group PCV
- Group PCV-VG
Conditions studied
- Anesthesia — all drugs for Anesthesia →
Sponsor
Hallym University Medical Center
Who can join
Adults 20 to 65, female only, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Robot-assisted hysterectomy is associated with pneumoperioneum with CO2 and Trendelenburg position, which may have adverse cardiopulmonary effects. A new ventilation mode; pressure-controlled ventilation with volume guaranteed mode (PCV-VG) delivers constant tidal volume with constant inspiratory pressure, using a decelerating flow pattern. This prospective, randomized study is designed to compare the effects of PCV-VG, volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) on respiratory and hemodynamic variables in patients undergoing Robot-assisted hysterectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03887949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group VCV
Trials testing the same drug.
- NCT03571854 — The Effect of Pressure-controlled Ventilation-volume Guaranteed Mode · NA · unknown
Other recruiting trials for Anesthesia
Currently open trials in the same condition.
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other Hallym University Medical Center trials
Trials by the same sponsor.
- NCT06688565 — A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients · NA · unknown
- NCT06175169 — IA Model for Acute Appendicitis in CT · NA · unknown
- NCT05768997 — High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia · Phase 3 · unknown
- NCT05439993 — Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma · Phase 1, PHASE2 · recruiting
- NCT04787354 — Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX) · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03887949 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hallym University Medical Center
- Last refreshed: 25 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03887949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing